<p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）于周二发布了季度财报。该公司报告每股收益（EPS）为（$0.27），低于分析师一致预期的（$0.19），差距为（$0.08），FiscalAI 报道。CryoPort 的股本回报率为负的 11.07%，净利润率为 35.57%。该公司本季度的收入为 4545 万美元，而分析师的预期为 4292 万美元。</p>
<h2>CryoPort 股价上涨 3.4%</h2>
<p>周二，CryoPort 股票在交易时段上涨了 0.28 美元，达到 8.49 美元。该公司的交易量为 774,827 股，而其平均交易量为 355,334 股。该公司的债务与股本比率为 0.40，流动比率为 15.77，速动比率为 15.01。CryoPort 的 12 个月低点为 4.58 美元，12 个月高点为 11.45 美元。该公司的 50 日移动平均价格为 9.54 美元，200 日移动平均价格为 9.41 美元。该公司的市值为 4.2509 亿美元，市盈率为 7.26，贝塔值为 1.69。</p>
<h2>内部交易活动</h2>
<p>在相关消息中，董事 Ramkumar Mandalam 于 12 月 10 日（星期三）出售了 11,570 股 CryoPort 股票。股票以平均价格 9.99 美元出售，总价值为 115,584.30 美元。交易后，该董事直接持有 80,758 股公司股票，价值 806,772.42 美元。此次交易使其持股减少了 12.53%。该出售在向证券交易委员会的备案中披露，相关文件可通过此链接获取。公司内部人士持有 10.10% 的公司股票。</p>
<h2>对 CryoPort 的对冲基金看法</h2>
<p>一些对冲基金最近调整了对 CYRX 的持股。瑞银集团（UBS Group AG）在第三季度将其在 CryoPort 的持股增加了 112.7%。瑞银集团目前持有 1,331,521 股公司股票，价值 12,623,000 美元，此前在该期间购买了额外的 705,649 股。千禧管理公司（Millennium Management LLC）在第四季度将其在 CryoPort 的持股提高了 23.8%。千禧管理公司目前持有 3,244,802 股公司股票，价值 31,150,000 美元，此前在上个季度购买了额外的 623,896 股。雅各布斯·莱维股权管理公司（Jacobs Levy Equity Management Inc.）在第三季度将其在 CryoPort 的持股提高了 283.1%。雅各布斯·莱维股权管理公司目前持有 524,288 股公司股票，价值 4,970,000 美元，此前在上个季度购买了额外的 387,440 股。Mak Capital One LLC 在第四季度将其在 CryoPort 的持股提高了 46.6%。Mak Capital One LLC 目前持有 1,199,225 股公司股票，价值 11,513,000 美元，此前在该期间购买了额外的 381,063 股。最后，帝国金融管理公司（Empire Financial Management Company LLC）在第四季度将其在 CryoPort 的持股增加了 141.8%。帝国金融管理公司目前持有 403,861 股公司股票，价值 3,877,000 美元，此前在上个季度购买了额外的 236,861 股。对冲基金和其他机构投资者持有公司 92.90% 的股票。</p>
<h2>分析师评级变动</h2>
<p>CYRX 最近成为多份研究报告的主题。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CryoPort 股票的 “卖出（d+）” 评级。Needham &amp; Company LLC 在 11 月 5 日的报告中将 CryoPort 股票的目标价从 11.00 美元上调至 12.00 美元，并给予该公司 “买入” 评级。最后，瑞银集团在 11 月 5 日的研究报告中将 CryoPort 股票的目标价从 11.00 美元上调至 12.50 美元，并给予该公司 “买入” 评级。八位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，CryoPort 目前的平均评级为 “适度买入”，共识目标价为 12.83 美元。</p>
<p><strong>查看我们最新的 CryoPort 股票报告</strong></p>
<h2>关于 CryoPort</h2>
<p>（获取免费报告）</p>
<p>CryoPort, Inc（纳斯达克代码：CYRX）是生命科学行业温控物流解决方案的全球提供商。该公司专注于关键生物材料的低温运输，支持细胞和基因疗法、生物制剂、疫苗和生殖医学的开发、临床测试和商业化。通过提供端到端的供应链管理，CryoPort 帮助确保温度敏感产品从起点到目的地的完整性和可行性。</p>
<p>CryoPort 的产品组合包括专有的低温干货运输设备、先进的主动和被动热包装以及实时数据监控平台。</p>
<h2>另见</h2>
<ul>
<li>我们更看好的五只股票比 CryoPort 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>警报：在明天市场开盘前抛售这五只股票！</li>
</ul>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1,000 美元在 CryoPort 吗？</h2>
<p>在你考虑 CryoPort 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CryoPort 并不在名单上。</p>
<p>虽然 CryoPort 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

CYRX

<p>CryoPort（纳斯达克代码：CYRX）报告的季度每股收益为（$0.27），低于预期$0.08。尽管收入为 4545 万美元，超出预期，但公司股本回报率为负 11.07%。股票上涨 3.4%，至 8.49 美元，市值为 4.2509 亿美元。对冲基金增加了持股，分析师评级显示共识为 “适度买入”，目标价格为 12.83 美元。内部交易方面，一名董事出售了股份，减少了 12.53% 的持股</p>

<p>CryoPort (NASDAQ:CYRX - Get Free Report) posted its quarterly earnings data on Tuesday. The company reported ($0.27) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.19) by ($0.08), FiscalAI reports. CryoPort had a negative return on equity of 11.07% and a net margin of 35.57%.The company had revenue of $45.45 million for the quarter, compared to analysts' expectations of $42.92 million.</p>
<div class="lb-trans"><p>CryoPort（纳斯达克代码：CYRX - 获取免费报告）于周二发布了季度财报。该公司报告每股收益（EPS）为（$0.27），低于分析师一致预期的（$0.19），差距为（$0.08），FiscalAI 报道。CryoPort 的股本回报率为负的 11.07%，净利润率为 35.57%。该公司本季度的收入为 4545 万美元，而分析师的预期为 4292 万美元。</p>
</div><h2>CryoPort Trading Up 3.4%</h2>
<div class="lb-trans"><h2>CryoPort 股价上涨 3.4%</h2>
</div><p>CryoPort stock traded up $0.28 during trading hours on Tuesday, reaching $8.49. The company had a trading volume of 774,827 shares, compared to its average volume of 355,334. The company has a debt-to-equity ratio of 0.40, a current ratio of 15.77 and a quick ratio of 15.01. CryoPort has a 12-month low of $4.58 and a 12-month high of $11.45. The company has a 50-day moving average price of $9.54 and a 200 day moving average price of $9.41. The firm has a market cap of $425.09 million, a price-to-earnings ratio of 7.26 and a beta of 1.69.</p>
<div class="lb-trans"><p>周二，CryoPort 股票在交易时段上涨了 0.28 美元，达到 8.49 美元。该公司的交易量为 774,827 股，而其平均交易量为 355,334 股。该公司的债务与股本比率为 0.40，流动比率为 15.77，速动比率为 15.01。CryoPort 的 12 个月低点为 4.58 美元，12 个月高点为 11.45 美元。该公司的 50 日移动平均价格为 9.54 美元，200 日移动平均价格为 9.41 美元。该公司的市值为 4.2509 亿美元，市盈率为 7.26，贝塔值为 1.69。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部交易活动</h2>
</div><p>In related news, Director Ramkumar Mandalam sold 11,570 shares of CryoPort stock in a transaction on Wednesday, December 10th. The shares were sold at an average price of $9.99, for a total value of $115,584.30. Following the transaction, the director directly owned 80,758 shares of the company's stock, valued at $806,772.42. The trade was a 12.53% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities &amp; Exchange Commission, which is available through this link. Corporate insiders own 10.10% of the company's stock.</p>
<div class="lb-trans"><p>在相关消息中，董事 Ramkumar Mandalam 于 12 月 10 日（星期三）出售了 11,570 股 CryoPort 股票。股票以平均价格 9.99 美元出售，总价值为 115,584.30 美元。交易后，该董事直接持有 80,758 股公司股票，价值 806,772.42 美元。此次交易使其持股减少了 12.53%。该出售在向证券交易委员会的备案中披露，相关文件可通过此链接获取。公司内部人士持有 10.10% 的公司股票。</p>
</div><h2>Hedge Funds Weigh In On CryoPort</h2>
<div class="lb-trans"><h2>对 CryoPort 的对冲基金看法</h2>
</div><p>A number of hedge funds have recently modified their holdings of CYRX. UBS Group AG boosted its holdings in shares of CryoPort by 112.7% during the third quarter. UBS Group AG now owns 1,331,521 shares of the company's stock worth $12,623,000 after purchasing an additional 705,649 shares during the period. Millennium Management LLC raised its position in CryoPort by 23.8% during the 4th quarter. Millennium Management LLC now owns 3,244,802 shares of the company's stock valued at $31,150,000 after purchasing an additional 623,896 shares during the last quarter. Jacobs Levy Equity Management Inc. raised its position in CryoPort by 283.1% during the 3rd quarter. Jacobs Levy Equity Management Inc. now owns 524,288 shares of the company's stock valued at $4,970,000 after purchasing an additional 387,440 shares during the last quarter. Mak Capital One LLC lifted its holdings in CryoPort by 46.6% in the 4th quarter. Mak Capital One LLC now owns 1,199,225 shares of the company's stock worth $11,513,000 after buying an additional 381,063 shares during the period. Finally, Empire Financial Management Company LLC grew its position in shares of CryoPort by 141.8% in the 4th quarter. Empire Financial Management Company LLC now owns 403,861 shares of the company's stock worth $3,877,000 after buying an additional 236,861 shares during the last quarter. Hedge funds and other institutional investors own 92.90% of the company's stock.</p>
<div class="lb-trans"><p>一些对冲基金最近调整了对 CYRX 的持股。瑞银集团（UBS Group AG）在第三季度将其在 CryoPort 的持股增加了 112.7%。瑞银集团目前持有 1,331,521 股公司股票，价值 12,623,000 美元，此前在该期间购买了额外的 705,649 股。千禧管理公司（Millennium Management LLC）在第四季度将其在 CryoPort 的持股提高了 23.8%。千禧管理公司目前持有 3,244,802 股公司股票，价值 31,150,000 美元，此前在上个季度购买了额外的 623,896 股。雅各布斯·莱维股权管理公司（Jacobs Levy Equity Management Inc.）在第三季度将其在 CryoPort 的持股提高了 283.1%。雅各布斯·莱维股权管理公司目前持有 524,288 股公司股票，价值 4,970,000 美元，此前在上个季度购买了额外的 387,440 股。Mak Capital One LLC 在第四季度将其在 CryoPort 的持股提高了 46.6%。Mak Capital One LLC 目前持有 1,199,225 股公司股票，价值 11,513,000 美元，此前在该期间购买了额外的 381,063 股。最后，帝国金融管理公司（Empire Financial Management Company LLC）在第四季度将其在 CryoPort 的持股增加了 141.8%。帝国金融管理公司目前持有 403,861 股公司股票，价值 3,877,000 美元，此前在上个季度购买了额外的 236,861 股。对冲基金和其他机构投资者持有公司 92.90% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>CYRX has been the topic of a number of recent research reports. Weiss Ratings reaffirmed a &#34;sell (d+)&#34; rating on shares of CryoPort in a research report on Monday, December 29th. Needham &amp; Company LLC raised their price target on shares of CryoPort from $11.00 to $12.00 and gave the company a &#34;buy&#34; rating in a report on Wednesday, November 5th. Finally, UBS Group boosted their price target on shares of CryoPort from $11.00 to $12.50 and gave the company a &#34;buy&#34; rating in a research report on Wednesday, November 5th. Eight equities research analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat, CryoPort presently has an average rating of &#34;Moderate Buy&#34; and a consensus target price of $12.83.</p>
<div class="lb-trans"><p>CYRX 最近成为多份研究报告的主题。Weiss Ratings 在 12 月 29 日的研究报告中重申了对 CryoPort 股票的 “卖出（d+）” 评级。Needham &amp; Company LLC 在 11 月 5 日的报告中将 CryoPort 股票的目标价从 11.00 美元上调至 12.00 美元，并给予该公司 “买入” 评级。最后，瑞银集团在 11 月 5 日的研究报告中将 CryoPort 股票的目标价从 11.00 美元上调至 12.50 美元，并给予该公司 “买入” 评级。八位股票研究分析师对该股票给予了买入评级，一位给予了持有评级，一位给予了卖出评级。根据 MarketBeat 的数据，CryoPort 目前的平均评级为 “适度买入”，共识目标价为 12.83 美元。</p>
</div><p><strong>View Our Latest Stock Report on CryoPort</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 CryoPort 股票报告</strong></p>
</div><h2>About CryoPort</h2>
<div class="lb-trans"><h2>关于 CryoPort</h2>
</div><p>(Get Free Report)</p>
<div class="lb-trans"><p>（获取免费报告）</p>
</div><p>CryoPort, Inc NASDAQ: CYRX is a global provider of temperature-controlled logistics solutions for the life sciences industry. The company specializes in cryogenic shipping for critical biological materials, supporting the development, clinical testing and commercialization of cell and gene therapies, biologics, vaccines and reproductive medicine. By offering end-to-end supply chain management, CryoPort helps ensure the integrity and viability of temperature-sensitive products from point of origin to destination.</p>
<div class="lb-trans"><p>CryoPort, Inc（纳斯达克代码：CYRX）是生命科学行业温控物流解决方案的全球提供商。该公司专注于关键生物材料的低温运输，支持细胞和基因疗法、生物制剂、疫苗和生殖医学的开发、临床测试和商业化。通过提供端到端的供应链管理，CryoPort 帮助确保温度敏感产品从起点到目的地的完整性和可行性。</p>
</div><p>CryoPort's product portfolio includes proprietary cryogenic dry shippers, advanced active and passive thermal packaging, and real-time data monitoring platforms.</p>
<div class="lb-trans"><p>CryoPort 的产品组合包括专有的低温干货运输设备、先进的主动和被动热包装以及实时数据监控平台。</p>
</div><h2>See Also</h2>
<div class="lb-trans"><h2>另见</h2>
</div><ul>
<li>Five stocks we like better than CryoPort</li>
<li>The gold chart Wall Street is terrified of…</li>
<li>America’s 1776 happening again</li>
<li>Buy this Gold Stock Before May 2026</li>
<li>What a Former CIA Agent Knows About the Coming Collapse</li>
<li>ALERT: Drop these 5 stocks before the market opens tomorrow!</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票比 CryoPort 更好</li>
<li>华尔街害怕的黄金图表……</li>
<li>美国的 1776 再次发生</li>
<li>在 2026 年 5 月之前购买这只黄金股票</li>
<li>一位前 CIA 特工对即将到来的崩溃的看法</li>
<li>警报：在明天市场开盘前抛售这五只股票！</li>
</ul>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/EarningsChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9Q1lSWA" alt="" original-src="https://www.marketbeat.com/scripts/EarningsChart.ashx?Prefix=NASDAQ&amp;Symbol=CYRX"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in CryoPort Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在 CryoPort 吗？</h2>
</div><p>Before you consider CryoPort, you'll want to hear this.</p>
<div class="lb-trans"><p>在你考虑 CryoPort 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and CryoPort wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，以便在更广泛的市场注意到之前购买……而 CryoPort 并不在名单上。</p>
</div><p>While CryoPort currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 CryoPort 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

CryoPort（NASDAQ:CYRX）公布了财报，每股收益比预期低 0.08 美元